The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
The conundrum of depression clinical trials: one size does not fit all
Open accessAbstract
In this paper we review the history of antidepressant (AD) development, since the discovery of imipramine in 1957 to the present day. Through this exploration we will show that the increasing placebo response is likely a red herring and that a higher magnitude of placebo response is not an adequate explanation for AD trials' high failure rates. As a better explanation for their lack of success, we will examine some of the fundamental flaws of AD clinical trials and their origins in historical forces. We focus on underpowering, which occurs as a consequence of unrealistic expectations for AD performance. In addition, we describe the lack of precision in the depression outcome measurements for the past 40 years and show how these measures contrast with those used in clinical trials of other chronic diseases, which use simpler outcome measures. Finally, we describe the role of regulatory agencies in influencing clinical trial design and how the assumption that 'one size fits all' for the past 60 years has led to flawed design of AD clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 Co-occurrence of 52 depression symptoms across seven depression rating scales. Colored circles for a symptom indicate that a scale directly assesses that symptom, while empty circles indicate that a scale only measures a symptom indirectly. For instance, the IDS assesses item 4 hypersomnia directly; the BDI measures item 4 indirectly by a general question on sleep problems; and the SDS does not capture item 4 at all. Note that the nine QIDS items analyzed correspond exactly to the DSM-5 criterion symptoms for MDD. BDI, 21-item Beck Depression Inventory-II; CESD, Center for Epidemiologic Studies Depression Scale; DSM-5, Diagnostic and Statistical Manual, 5th ed.; HRSD, Hamilton Rating Scale for Depression; IDS, Inventory of Depressive Symptoms; MADRS, Montgomery-Asberg Depression Rating Scale; SDS, Zung Self-Rating Depression Scale; QIDS, Quick Inventory of Depressive Symptoms. Reprinted from: Fried (2017). Copyright [Elsevier], [Amsterdam, Netherlands]. All permission requests for this image should be made to the copyright holder.](https://figures.cochat.ai/paper-figures/a5cbdc1b8e17499b86d3cee61c785802/the-conundrum-of-depression-clinical-trials-one-size-does-not-fit-all-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, “blockbuster drugs” for neurobehavioural conditions have not yielded blockbuster improvements.”
From Precision clinical trials: a framework for getting to precision medicine for neurobehavioural disorders (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“First, patient subgroups are defined by baseline pre-randomization markers that are hypothesized to modulate the effect size of the intervention (i.e., modulators), an approach commonly used in cardiovascular disease, for example.”
From Precision clinical trials: a framework for getting to precision medicine for neurobehavioural disorders (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This flawed approach fails to take into account the complexity of neurobehavioural disorders in 3 ways.9,34–37”
From Precision clinical trials: a framework for getting to precision medicine for neurobehavioural disorders (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredIn the citing paper
“For example, placebo-controlled trials in depression and anxiety disorders have shown very small average effect sizes.9,10,11”
From Precision clinical trials: a framework for getting to precision medicine for neurobehavioural disorders (2021) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 2×
“Intrigued by this new class of ‘antidepressant’ drugs, Hamilton (1960) put together a rating scale intended to measure the severity of depression symptoms.”
BackgroundMethodWhy Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020124 · Cited by 10,505
Power failure: why small sample size undermines the reliability of neuroscience
Button, K. S., Ioannidis, J. P. A., Mokrysz, C., Nosek, B. A., Flint, J., Robinson, E. S. J., & Munafò, M. R. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3475 · Cited by 7,641 · cited 1×
“Perhaps we were not heeding the risks of low statistical power well enough, as has been the case in many scientific fields (Cohen, 1962; Freiman et al., 1978; Sedlmeier and Gigerenzer, 1989; Halpern et al., 2002; Maxwell, 2004; Button et al., 2013).”
BackgroundWhy Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · CHANCE · doi:10.1080/09332480.2005.10722754 · Cited by 4,702 · cited 2×
“Even more importantly, the estimates of the treatment effect size gleaned from such studies are likely to be overestimates in the case of positive studies and underestimates of the true effect if the study was negative (Ioannidis, 2005; Chmura Kraemer et al., 2006; Gibertini et al., 2012; Reinhart, 2015; Blackford, 20…”
BackgroundBelief in the law of small numbers.
Tversky, A., & Kahneman, D. (1971) · Psychological Bulletin · doi:10.1037/h0031322 · Cited by 3,246 · cited 1×
“Perhaps it is the ‘belief in the law of small numbers’ that we are all susceptible to, where the rules of large samples are incorrectly applied to small samples (Tversky and Kahneman, 1971).”
BackgroundKirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442 · cited 1×
“Some investigators have suggested that ADs were not effective (Kirsch et al., 2008; Fournier et al., 2010).”
BackgroundSelective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435 · cited 1×
“It is also likely that these lucky results are disproportionately available for analysis because of selection or publication bias (Turner et al., 2008).”
BackgroundCarroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243 · cited 1×
“Yet the search for depression biomarkers has not been fruitful (Carroll et al., 1981; Hasler, 2010).”
BackgroundAntidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J. (2010) · JAMA · doi:10.1001/jama.2009.1943 · Cited by 2,009 · cited 1×
“Some investigators have suggested that ADs were not effective (Kirsch et al., 2008; Fournier et al., 2010).”
BackgroundThe role and interpretation of pilot studies in clinical research
Leon, A. C., Davis, L. L., & Kraemer, H. C. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.10.008 · Cited by 1,917 · cited 1×
“As Leon et al. (2011) stated: ‘A pilot study is not a hypothesis testing study…[because] a pilot study does not provide a meaningful effect size estimate for planning subsequent studies due to the imprecision inherent in data from small samples.’”
Background
Research works printed but not linked: 2
- Demitrack, 1998, Psychopharmacol Bull, 34, 19
- Khan, 2003a, J Nerv Ment Dis, 191, 211
Cited by
Chevance, A., Ravaud, P., Tomlinson, A., Le Berre, C., Teufer, B., Touboul, S., Fried, E. I., Gartlehner, G., Cipriani, A., & Tran, V. T. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30191-7 · Cited by 193
Poor Separation of Clinical Symptom Profiles by DSM-5 Disorder Criteria
Newson, J. J., Pastukh, V., & Thiagarajan, T. C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.775762 · Cited by 104
“This likely contributes substantially to the challenge of obtaining clear results in clinical trials where outcomes are rarely unequivocal and typically successful for a low proportion of patients (15).”
BackgroundGlue, P., Loo, C. K. A., Fam, J., Lane, H., Young, A. H., Surman, P., BEDROC study investigators, Glozier, N., Fitzgerald, P. B., Liu, D., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03063-x · Cited by 78
“11,12).”
Lenze, E. J., Nicol, G. E., Barbour, D. L., Kannampallil, T., Wong, A. W. K., Piccirillo, J., Drysdale, A. T., Sylvester, C. M., Haddad, R., Miller, J. P., et al. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.200042 · Cited by 43
Smith, S. M., D, M. F. M., Jensen, M. P., Mbowe, O. B., McDermott, M. P., Turk, D. C., & Dworkin, R. H. (2020) · Pain · doi:10.1097/j.pain.0000000000001849 · Cited by 41
“meta-analyses of efficacious antidepressants for major depression.(43,61,62) Antidepressant trials share with analgesic RCTs several methodologic characteristics that might contribute to”
Background
Metadata
- Authors
- Khan, A., Mar, K. F., & Brown, W. A.
- Affiliations
- Duke University (US)
- Northwest Clinical Research Center (US)
- Brown University (US)
- Corresponding author
- Khan, Arif
- Venue
- International Clinical Psychopharmacology
- Published
- 2018-09
- Volume
- 33
- Issue
- 5
- Pages
- 239-248
- ISSN
- 0268-1315 (ISSN-L)
- PMC
- PMC6078483
- OpenAlex
- W2808933129
- Cited by
- 30
- References
- 61
- Citations by year
- 2025: 6 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 6 · 2020: 6 · 2019: 5
- FWCI
- 0.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- International Clinical Psychopharmacology (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Biomedical Research Council
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
- Keywords
- antidepressant drug development, placebo response, underpowered trials, imipramine, history of antidepressants
- MeSH terms
- Antidepressive Agents, Clinical Trials as Topic, Depressive Disorder, Humans, Imipramine, Placebos, History, 20th Century, History, 21st Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The conundrum of depression clinical trials: one size does not fit all. https://app.cochat.ai/papers/10.1097/yic.0000000000000229
- The paper
- Khan, A., Mar, K. F., & Brown, W. A. (2018). The conundrum of depression clinical trials: one size does not fit all. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0000000000000229
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.